Faculty profile

Mark Basik

ResearcherSocial Studies of MedicineMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Mark Basik

Researcher

Social Studies of Medicine

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
46 publications in the last five years, latest in 2026.
Senior (last) author on 8 recent papers, a sign of leading a research group.
Principal investigator on 8 research grants (8 CIHR), most recently in 2025.
Supervised 4 trainees who won CIHR awards, most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

111

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Breast Cancer Pembrolizumab Ctdna Tnbc Triple Negative Breast Cancer Neoadjuvant Chemotherapy Drug Resistance Clinical Risk Factors

Latest papers

Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC.
Cell reports. Medicine · 2026
ASO Visual Abstract: Impact of Ethnicity on the Uptake of Risk-Reducing Mastectomy in Unaffected BRCA1/2 and PALB2 Carriers in Canada.
Annals of surgical oncology · 2026
ATR and PKMYT1 Inhibition Resensitizes a Subset of TNBC Patient-Derived Models to Carboplatin, Inducing Mitotic Catastrophe.
Cancer research communications · 2026 · senior author

All 111 publications

Latest funding

Advancing Risk Stratification in Young Women at High Risk for Breast Cancer
CIHR · 2025 · Nominated PI
$999,975
Altering the gut microbiome in Triple- negative breast cancer: a pilot study
CIHR · 2024 · Nominated PI
$1,510,875
Cancer Translational Research Horizons 2024
CIHR · 2024 · Co-investigator
$20,000

All 16 grants and awards

111 publications.

Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC.

Saatci O, Ulukan B, Cetin M, Kuasne H, Martinez C, Percin E, Oleinik N, Savoca MT, Nehme A, Hernández-Corchado A, Zavacky E, Sreenivas K, Rezaeian AH, Bethard JR, Anoma JS, Sahin OS, Aguilar-Mahecha A, Buchanan M, Aras M, DeBlois G, Basik M, Hill EG, Ball LE, Rao CN, McInnes C, Riazalhosseini Y, Najafabadi HS, Lemasters JJ, Ogretmen B, Park M, Sahin O

Cell reports. Medicine2026

DOI: 10.1016/j.xcrm.2026.103015 PMID: 42673947

ASO Visual Abstract: Impact of Ethnicity on the Uptake of Risk-Reducing Mastectomy in Unaffected BRCA1/2 and PALB2 Carriers in Canada.

Mashal S, Melanson A, Apostolova C, Ferroum A, Villareal-Corpuz V, Meterissian S, Martel K, Boileau JF, Basik M, Foulkes W, Wong SM, Prakash I

Annals of surgical oncology2026

DOI: 10.1245/s10434-026-19561-w PMID: 41954713

ATR and PKMYT1 Inhibition Resensitizes a Subset of TNBC Patient-Derived Models to Carboplatin, Inducing Mitotic Catastrophe.

Guay J, Kuasne H, Chabot C, Bozek K, Majedi Y, Buchanan M, Aguilar-Mahecha A, Bareke E, Ulmer B, Kong T, Yang K, Liao M, Elebute O, Guo R, Monast A, Morin G, Huang S, Park M, Basik M

Cancer research communications2026Senior author

DOI: 10.1158/2767-9764.crc-25-0044 PMID: 41973002

ASO Visual Abstract: Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose Tamoxifen.

Cuillerier NJS, Almarzooqi H, Corpuz VV, Saboobheh S, Prakash I, Basik M, Boileau JF, Martel K, Meterissian S, Pollak M, Wong SM

Annals of surgical oncology2026

DOI: 10.1245/s10434-026-19288-8 PMID: 41824212

Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose Tamoxifen.

Cuillerier NJS, Almarzooqi H, Villareal-Corpuz V, Sabboobeh S, Prakash I, Basik M, Boileau JF, Martel K, Meterissian S, Pollak M, Wong SM

Annals of surgical oncology2026

DOI: 10.1245/s10434-026-19100-7 PMID: 41654661

Trends in breast reconstruction for BRCA1/2, PALB2 and other high penetrance germline pathogenic variant carriers undergoing risk reducing mastectomy.

Melanson A, Alsuhaibani M, Viezel-Mathieu A, Dionisopoulos T, Basik M, Boileau JF, Martel K, Prakash I, Meterissian S, Vorstenbosch J, Foulkes WD, Wong SM

Familial cancer2026

DOI: 10.1007/s10689-026-00564-1 PMID: 42047902

Clinical Validation of Digital PCR-Based ctDNA Detection for Risk Stratification in Residual Triple-Negative Breast Cancer: TRICIA Trial Results.

Roseshter T, Klemantovich A, Lafleur J, Lan C, Cavallone L, Bozek K, Guay J, Elebute O, Jenna S, Ouellette R, McNamara S, Boileau JF, Pelmus M, Brackstone M, Pezo R, Ng T, Aguilar-Mahecha A, Basik M

Clinical cancer research : an official journal of the American Association for Cancer Research2026Senior author

DOI: 10.1158/1078-0432.ccr-25-2234 PMID: 41662447

Mechanisms of resistance to antibody-drug conjugates in breast cancer.

Cerci B, Saatci O, Basik M, Sahin O

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy2026

DOI: 10.1016/j.drup.2026.101353 PMID: 41518796

ASO Visual Abstract: Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing After 60 Years of Age.

Melanson A, Mashal S, Apostolova C, Ferroum A, Basik M, Boileau JF, Martel K, Meterissian S, Wong N, Weber E, Foulkes WD, Prakash I, Wong SM

Annals of surgical oncology2026

DOI: 10.1245/s10434-025-18678-8 PMID: 41212459

Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing after 60 Years of Age.

Melanson A, Mashal S, Apostolova C, Ferroum A, Basik M, Boileau JF, Martel K, Meterissian S, Wong N, Weber E, Foulkes WD, Prakash I, Wong SM

Annals of surgical oncology2026

DOI: 10.1245/s10434-025-18343-0 PMID: 40996624

Something wrong or missing on this profile? Suggest a correction

Mark Basik

Research

Latest papers

Latest funding

Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC.

ASO Visual Abstract: Impact of Ethnicity on the Uptake of Risk-Reducing Mastectomy in Unaffected BRCA1/2 and PALB2 Carriers in Canada.

ATR and PKMYT1 Inhibition Resensitizes a Subset of TNBC Patient-Derived Models to Carboplatin, Inducing Mitotic Catastrophe.

ASO Visual Abstract: Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose Tamoxifen.

Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose Tamoxifen.

Trends in breast reconstruction for BRCA1/2, PALB2 and other high penetrance germline pathogenic variant carriers undergoing risk reducing mastectomy.

Clinical Validation of Digital PCR-Based ctDNA Detection for Risk Stratification in Residual Triple-Negative Breast Cancer: TRICIA Trial Results.

Mechanisms of resistance to antibody-drug conjugates in breast cancer.

ASO Visual Abstract: Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing After 60 Years of Age.

Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing after 60 Years of Age.

Frequent collaborators

Sarkis Meterissian

Ipshita Prakash

Gerald Batist

Gerald Batist

Morag Park

Michael Pollak

Jacek Majewski

Yvonne Bombard

William Foulkes

Catalin Mihalcioiu

Aaron Pollett

Lesa Dawson

Morag Park

Alberto Cambrosio

Lawrence Panasci

ATILLA Omeroglu

Michael Witcher

Muriel Brackstone

Aly Karsan

Luke McCaffrey

Sylvain Meloche

Kevin Petrecca

Moulay Alaoui-Jamali

Thierry Muanza

Elena` Parvez

Julie St-Pierre

Elena Parvez

David Malkin

Ivan Topisirovic

Sidong Huang

Stephanie Wong

Jonathan Spicer

Tiziana Cotechini

Talia Malagon

Stephanie Lheureux

Karineh Kazazian

Patrick Veit-Haibach

Leigh Murphy

Daniel Lamarre

Wei Xu